Hemp provisions of a large-scale agriculture funding bill that is advancing in the House could “create confusion” for the industry due to a lack of clarity around the type of allowable products, congressional researchers say.
In a report from the Congressional Research Service (CRS) that was published on Monday, analysts looked at proposed changes to federal hemp rules under two pieces of legislation that recently moved through committee and that have stirred controversy among cannabis stakeholders.
Most of the report focuses on how the measures as amended would effectively ban many consumable hemp-derived cannabinoids, including CBD products containing any “quantifiable amounts” of THC. It would also clarify that intoxicating synthetic cannabinoids such as delta-8 THC are prohibited.
“Congress is continuing to debate these proposed changes as it proceeds to consider these bills,” CRS said. “These provisions have both supporters and detractors.”
Supporters include prohibitionist groups and certain major marijuana companies, while the hemp industry largely opposes the language, even if stakeholders generally agree that there’s a need to create a regulatory framework for consumable hemp products to address public health concerns that have emerged since the crop and its derivatives were federally legalized under the 2018 Farm Bill.
CRS said
Read full article on Marijuana Moment
